Results 1 to 10 of about 2,263,596 (244)

Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy

Molecules, 2017
Duane Miller, Kinsie Arnst, Zongtao Lin   +2 more
exaly  

Challenges and new frontiers in analytical characterization of antibody-drug conjugates

MAbs, 2018
Hangtian Song, Tapan K Das, Tapan Das
exaly  

From Anthramycin to Pyrrolobenzodiazepine (PBD)‐Containing Antibody–Drug Conjugates (ADCs)

Angewandte Chemie - International Edition, 2017
David Thurston, Khondaker Miraz Rahman, Julia Mantaj   +2 more
exaly  

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice

International Journal of Molecular Sciences, 2012
Nathan Cantoni
exaly  

Antibody-drug conjugates

2018
LIN NAN-HORNG, TSAI CHARNG-SHENG, HUNG TING-CHUN, CHUANG HONG-YANG   +3 more
openaire   +4 more sources

Factors Affecting the Pharmacology of Antibody–Drug Conjugates

Antibodies, 2018
Andrew Lucas, William Zamboni
exaly  

Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy

Angewandte Chemie - International Edition, 2014
Wayne Widdison, Michael Miller
exaly  

Antibody-drug conjugates and methods

2006
EBENS JR ALLEN J, JACOBSON FREDERIC S, POLAKIS PAUL, SCHWALL RALPH H, SLIWKOWSKI MARK X, SPENCER SUSAN D   +5 more
openaire   +11 more sources

The Role of Organic Synthesis in the Emergence and Development of Antibody–Drug Conjugates as Targeted Cancer Therapies

Angewandte Chemie - International Edition, 2019
Kyriacos Nicolaou, Stephan Rigol
exaly  

Strategies and challenges for the next generation of antibody–drug conjugates

Nature Reviews Drug Discovery, 2017
Alain Beck, Charles Dumontet, Nathalie Corvaia   +2 more
exaly